Actis Oncology

Company

A biotech company focused on radiopharmaceuticals, with a billion-dollar market cap and significant cash reserves. Its platform targets Nectin 4 and B7H3, with early clinical data expected soon.

Mentioned in 1 video

Videos Mentioning Actis Oncology

All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

All-In Podcast

A biotech company focused on radiopharmaceuticals, with a billion-dollar market cap and significant cash reserves. Its platform targets Nectin 4 and B7H3, with early clinical data expected soon.